4//SEC Filing
Radford Jason W. 4
Accession 0001209191-19-012300
CIK 0001131324other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:25 PM ET
Size
7.2 KB
Accession
0001209191-19-012300
Insider Transaction Report
Form 4
Radford Jason W.
Chief Legal Officer
Transactions
- Sale
Common Stock
2019-02-19$83.73/sh−619$51,831→ 34,888 total - Sale
Common Stock
2019-02-19$83.03/sh−2,889$239,878→ 35,507 total
Footnotes (5)
- [F1]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 15, 2018.
- [F2]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F3]Represents weighted average sale price. Actual sale prices ranged from $82.59 to $83.58.
- [F4]Includes an aggregate of 31,517 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F5]Represents weighted average sale price. Actual sale prices ranged from $83.63 to $83.97.
Documents
Issuer
GENOMIC HEALTH INC
CIK 0001131324
Entity typeother
Related Parties
1- filerCIK 0001649199
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 7:25 PM ET
- Size
- 7.2 KB